Danaher Corporation
DHR Healthcare Diagnostics & Research
Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024. In the quarter to June 2026, revenue grew 5.54%, EPS grew 59.7%, free cash flow grew 15.6% and total debt rose 49.2%, each against the same quarter a year earlier. Member of the S&P 500.
Follow DHR
Danaher Corporation (DHR) Free cash flow
Danaher Corporation's free cash flow for fiscal 2025 was $5.3B, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $5.5B. Over the past ten years it has ranged from $2.9B (fiscal 2017) to $7.4B (fiscal 2022); the current reading is higher than 55% of that period. Free cash flow has fallen for 3 consecutive fiscal years. Danaher Corporation ranks 2nd of 52 Diagnostics & Research companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $5.3B | (0.30%) |
| FY2024 | $5.3B | (8.35%) |
| FY2023 | $5.8B | (21.82%) |
| FY2022 | $7.4B | 3.91% |
| FY2021 | $7.1B | 31.59% |
| FY2020 | $5.4B | 62.78% |
| FY2019 | $3.3B | (3.34%) |
| FY2018 | $3.4B | 17.16% |
| FY2017 | $2.9B | (0.08%) |
| FY2016 | $2.9B | (12.16%) |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Jun 2026 | $1.3B | 16.59% |
| Mar 2026 | $1.1B | (38.67%) |
| Dec 2025 | $1.8B | 29.12% |
| Sep 2025 | $1.4B | 25.23% |
| 42 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| TMO Thermo Fisher Scientific Inc. compare | $7.4B |
| DHR Danaher Corporation | $5.5B |
| IQV IQVIA Holdings Inc. compare | $2.3B |
| A Agilent Technologies, Inc. compare | $1.3B |
| IDXX IDEXX Laboratories, Inc. compare | $1.2B |
| ILMN Illumina, Inc. compare | $931.0M |
| MTD Mettler-Toledo International, Inc. compare | $864.0M |
| WAT Waters Corporation compare | $366.6M |
| NTRA Natera, Inc. compare | $84.2M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on DHR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement